Markt für regenerative Medizin – Erkenntnisse aus globaler und regionaler Analyse – Prognose bis 2031

  • Report Code : TIPHE100001194
  • Category : Life Sciences
  • No. of Pages : 201
Buy Now

Der Markt für regenerative Medizin wurde im Jahr 2021 auf 11,77 Milliarden US-Dollar geschätzt und wird voraussichtlich die USA erreichen 37,48 Milliarden US-Dollar bis 2031; Es wird erwartet, dass sie von 2022 bis 2031 mit einer durchschnittlichen jährlichen Wachstumsrate von 17,9 % wachsen wird.

Regenerative Medizin ist ein innovativer Bereich der Medizin, der Methoden zum Ersatz/Regeneration menschlicher Zellen, Gewebe oder Organe entwickelt, um normale Funktionen wiederherzustellen. Es kann Gewebe oder Organe heilen, indem es die körpereigenen Reparaturmechanismen stimuliert. Die regenerative Medizin ermöglicht es Wissenschaftlern, Gewebe und Organe im Labor zu züchten und sie sicher in den Körper zu implantieren, wenn dieser sich nicht selbst heilen kann. 

Zunehmende Akzeptanz von Gentherapien, Stammzelltherapien und Tissue Engineering; wachsende Zahl von Zulassungen für Zell- und Gentherapien; und technologische Fortschritte im Bereich der regenerativen Medizin sind die Schlüsselfaktoren für das Marktwachstum. Allerdings behindern die hohen Kosten dieser Therapien die Marktexpansion.

Der Markt für regenerative Medizin wird auf der Grundlage von Typ, Anwendung und Geographie. Der Bericht bietet Einblicke und eine eingehende Analyse des Marktes für regenerative Medizin, wobei er verschiedene Parameter wie Markttrends, technologische Fortschritte und Marktdynamik sowie die Analyse der Wettbewerbslandschaft führender Marktteilnehmer hervorhebt.

Strategische Einblicke

Lukrative Regionen des Marktes für regenerative Medizin

Regenerative Medicine Market

< h3>Market Insights

Steigende Zahl der Zulassungen für Zell- und Gentherapien stärkt das Wachstum des Marktes für regenerative Medizin

Die wachsende Zahl von Zell- und Gentherapien dürfte das Marktwachstum vorantreiben. Beispielsweise hat die US-amerikanische Food and Drug Administration (FDA) im Mai 2022 die Novartis Kymriah CAR-T-Zelltherapie für erwachsene Patienten mit rezidiviertem oder refraktärem (r/r) follikulärem Lymphom (FL) zugelassen. Kymriah ist die erste zugelassene CAR-T-Zelltherapie, die gemeinsam von Novartis und der Perelman School of Medicine der University of Pennsylvania entwickelt wurde. Im Februar 2022 erhielt Janssen Biotech, Inc. die US-amerikanische FDA-Zulassung für sein CARVYKTI (Ciltacabtagene Autoleucel; Cilta-Cel) zur Behandlung von Erwachsenen mit rezidiviertem oder refraktärem multiplem Myelom.

  • Im August 2022 erhielt Bluebird Bio, Inc. die US-amerikanische FDA-Zulassung für sein Zynteglo (betibeglogene autotemcel), das erste zellbasierte Gentherapie zur Behandlung von Erwachsenen und pädiatrischen Patienten mit Beta-Thalassämie, die regelmäßig Transfusionen roter Blutkörperchen benötigen. 
  • Im März 2021 hat die US-amerikanische FDA Celgene zugelassen Abecma (Idecabtagene Vicleucel) der Corporation, eine zellbasierte Gentherapie zur Behandlung erwachsener Patienten mit multiplem Myelom, die nicht auf die Behandlung angesprochen haben oder deren Krankheit trotz verschiedener Therapiearten wieder zurückgefallen ist.
< h3>Type-Based Insights

Je nach Typ ist der Markt für regenerative Medizin in zellbasierte Immuntherapie und Zelltherapieprodukte, Tissue-Engineering-Produkte und Gentherapieprodukte unterteilt. Die zellbasierte Das Segment Immuntherapie und Zelltherapieprodukte hatte im Jahr 2021 den größten Marktanteil und wird voraussichtlich die höchste CAGR verzeichnen der Prognosezeitraum.

Regenerative Medicine Market

Anwendungsbasierte Erkenntnisse

Je nach Anwendung ist der Markt für regenerative Medizin in Muskel-Skelett-Erkrankungen, Wundversorgung, Onkologie, Augenerkrankungen und Diabetes unterteilt. Das Segment Onkologie hatte im Jahr 2021 den größten Marktanteil und wird voraussichtlich auch den höchsten verzeichnen CAGR im Zeitraum 2022–2031.

Die COVID-19-Pandemie hat Wachstumschancen für die Marktteilnehmer geschaffen, da die Entwicklung neuer Therapien für COVID-19-Patienten dringend erforderlich ist. Mehrere Forschungsprojekte wurden in der Zell- und Gentherapie-Forschungsbranche initiiert. Beispielsweise Im November 2021 startete Longeveron Inc. seine Phase-1-Studie, um die Sicherheit von mesenchymalen Stammzellen (LMSCs) von Longeveron bei Erwachsenen zu testen, die aufgrund von COVID-19 an einem leichten bis schweren akuten Atemnotsyndrom (ARDS) leiden.< /p>

Im Jahr 2022 hielt Nordamerika den größten Anteil am Markt für regenerative Medizin. Das Marktwachstum ist auf die steigenden Forschungs- und Entwicklungsaktivitäten im Bereich der regenerativen Medizin zurückzuführen. Der asiatisch-pazifische Raum wird voraussichtlich am schnellsten verzeichnen CAGR im Prognosezeitraum. China, Japan und Indien leisten den größten Beitrag zum Markt für regenerative Medizin in der Region. Die zunehmende Stammzellenforschung, die zunehmende staatliche Unterstützung für Zell- und Genforschung und Verbesserungen in der biotechnologischen Infrastruktur sind die treibenden Faktoren Marktwachstum in APAC.

Geografisch ist der Markt für regenerative Medizin in Nordamerika (USA, Kanada und Mexiko), Europa (Großbritannien, Deutschland, Frankreich, Italien, Spanien und das übrige Europa) unterteilt. Asien-Pazifik (China, Japan, Indien, Südkorea, Australien und der übrige asiatisch-pazifische Raum), der Nahe Osten und Afrika (die Vereinigten Arabischen Emirate, Saudi-Arabien, Afrika und der übrige Nahe Osten und Afrika) und der Süden & Mittelamerika (Brasilien, Argentinien und der Rest von Süd- und Mittelamerika).

Firmenprofile

  • Integra LifeSciences
  • Gilead Sciences, Inc.
  • Novartis AG 
  • Vericel Corporation
  • Wright Medical Group NV
  • MiMedx Group
  • Osiris Therapeutics, Inc.
  • Stryker Corporation
  • Spark Therapeutics, Inc.
  • Medtronic plc
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the expected CAGR of the Regenerative Medicine Market?

The Regenerative Medicine Market is expected to register a CAGR of 15.4% from 2023-2031.

What are the driving factors impacting the Regenerative Medicine Market?

The major factors impacting the Regenerative Medicine Market are: Growing Focus on Stem Cell Research, Rising Prevalence of Chronic Diseases, and Advancements in Gene Therapy

What are the future trends in the Regenerative Medicine Market?

Key future trends in this market are - Increase in stem cell research, Adoption of 3D bioprinting, Advances in tissue engineering

Which are the key players in the Regenerative Medicine Market?

Key companies in this market are: Integra LifeSciences Corporation, Gilead Sciences, Novartis, Vericel Corporation, Wright Medical MiMedx, Osiris Therapeutics, Stryker Corporation, Spark Therapeutics

What are the deliverable formats of Regenerative Medicine Market report?

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

What are the options available for the customization of this report?

Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1. Integra LifeSciences Corporation
2. Gilead Sciences
3. Novartis
4. Vericel Corporation
5. Wright Medical
6. MiMedx
7. Osiris Therapeutics
8. Stryker Corporation
9. Spark Therapeutics
10. Medtronic
11. 3M
12. Allergan Plc
13. Aspect Biosystems
14. Bluebird Bio
15. Amgen, Inc.
16. Smith and Nephew Plc
17. Corestem, Inc.
18. Organogenesis
19. Kite Pharma
20. Spark Therapeutics


Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.